ANADYS PHARMACEUTICALS INC 4
4 · ANADYS PHARMACEUTICALS INC · Filed Dec 12, 2006
Insider Transaction Report
Form 4
YAROSHEVSKY GLANVILLE MARY
Senior Director, Human Capital
Transactions
- Award
Stock Option (Right to Buy)
2006-12-08+32,500→ 32,500 totalExercise: $4.88From: 2007-12-08Exp: 2016-12-07→ Common Stock (32,500 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest and become exercisable one year from the date of the grant with the remaining shares subject to the option vesting in equal monthly installments evenly over the next three year period such that all shares subject to the option will be fully vested and exercisable as of December 8, 2010.